METHAMPHETAMINE-DEPENDENCE
Clinical trials for METHAMPHETAMINE-DEPENDENCE explained in plain language.
Never miss a new study
Get alerted when new METHAMPHETAMINE-DEPENDENCE trials appear
Sign up with your email to follow new studies for METHAMPHETAMINE-DEPENDENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Naltrexone-Bupropion combo curb meth addiction? new trial seeks answers
Disease control Recruiting nowThis Phase 3 trial tests whether a combination of extended-release naltrexone (Vivitrol) and bupropion XL (Wellbutrin) can help people with moderate to severe methamphetamine use disorder reduce their drug use. About 360 participants will receive either the active drugs or placeb…
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE3 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a Weight-Loss drug curb meth addiction? new trial aims to find out
Disease control Recruiting nowThis study tests whether semaglutide (Wegovy), a drug used for diabetes and weight loss, can help people with moderate to severe methamphetamine use disorder cut back or stop using. The trial has two parts: a small pilot study with 25 people, followed by a larger randomized trial…
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE2 • Sponsor: San Francisco Department of Public Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a prescription stimulant help people stay in treatment for meth addiction?
Disease control Recruiting nowThis study looks at whether giving a high-dose prescription stimulant (lisdexamfetamine) for 25 weeks is feasible and acceptable for people with moderate to severe methamphetamine use disorder. About 80 participants will receive either the drug or a placebo alongside their usual …
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Cash for clean tests: App-Based rewards aim to curb opioid and cocaine use
Disease control Recruiting nowThis study tests whether giving financial incentives for negative drug tests can help people with opioid, cocaine, or methamphetamine use disorder stay abstinent. Six hundred participants use a smartphone app to submit saliva tests. Some receive escalating or de-escalating reward…
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy aims to curb meth use in canadian trial
Disease control Recruiting nowThis study tests whether adding a high-dose stimulant medication and/or a reward-based program (contingency management) to standard care helps people reduce how often they use methamphetamine. About 440 adults with moderate to severe methamphetamine use disorder will be randomly …
Matched conditions: METHAMPHETAMINE-DEPENDENCE
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC